Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma

Journal:

Cancer Research

Published:

2026-05-15

DOI:

10.1158/0008-5472.can-25-2985

Affiliations:

10

Authors:

19

Go to article

Institutions	Authors	Share
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA)	8.750000	0.46
NIH NCI Center for Cancer Research (CCR), United States of America (USA)	2.500000	0.13
NIH National Center for Advancing Translational Sciences (NCATS), United States of America (USA)	2.500000	0.13
Riley Hospital for Children, IU Health, United States of America (USA)	2.000000	0.11
Johns Hopkins University (JHU), United States of America (USA)	1.500000	0.08
Oregon Health and Science University (OHSU), United States of America (USA)	1.000000	0.05
University of Maryland, Baltimore (UMB), United States of America (USA)	0.500000	0.03
Marlene and Stewart Greenebaum Comprehensive Cancer Center, United States of America (USA)	0.250000	0.01

Interested in Oncology and Carcinogenesis?